Second line Bladder Cancer Therapies When First Line Treatments Fail

Jennifer M. Taylor, MD, MPH, discusses risk-stratification in non-muscle invasive bladder cancer (NMIBC), definitions of treatment failure in this setting, and indicated workup for suspected failure. She then reviews salvage intravesical options under investigation in clinical trials for Bacillus Calmette-Guérin (BCG) unresponsive NMIBC.